Related Experiment Video
Updated: Apr 10, 2026

12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
15.4K
Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib
Alessandra Iurlo1, Daniele Cattaneo, Leonardo Boiocchi
1Oncohematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy, aiurlo@policlinico.mi.it.
Annals of Hematology
|June 18, 2015
Abstract
No abstract available in PubMed .

